Global Fluorescence-Guided Surgery System Market

Fluorescence-Guided Surgery System Comprehensive Study by Type (PDE system, VS3 iridium system, SPY system, Others), Application (Sentinel Lymph Node (SLN) Mapping, Identification of Solid Tumors, Lymphography, Angiography, Anatomical Imaging), End Users (Doctor, Physician, Patients, Others) Players and Region - Global Market Outlook to 2027

Fluorescence-Guided Surgery System Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Fluorescence-Guided Surgery System
Fluorescence guided surgery (FGS) is an imaging technique that allows the surgeon to see structures and types of tissue that may not be visible under white light conditions during a surgical procedure. Fluorescence-Guided Surgery System is an intraoperative medical technique that generates a real-time fluorescence image of the surgical region to help guide the procedure. In comparison to conventional imaging techniques such as CT and MRI, FGS can provide real-time imaging during surgery and is significantly less expensive and simpler to use. A fluorescent substance and a special microscope are used during surgery to show tumour margins (edges), allowing more of the tumour to be removed. The substance is ingested and is absorbed by rapidly growing cells. When viewed through a microscope with a special blue light, these cells light up. This could assist doctors in removing as much tumour as possible while preserving healthy tissue. The use of fluorescence-guided surgery in the treatment of certain types of brain tumours is being researched

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The Global market of Fluorescence-Guided Surgery System is included more number of player which are provide high number of services so the global market are less competition. In worldwide market of Fluorescence-Guided Surgery System the presented companies follow the new launch or innovation of product for increasing their revenue and growth. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Olympus (Japan), Karl Storz (Germany), Medtronic (Ireland), Novadaq Technologies, Inc. (United States), PerkinElmer (United States), Stryker (United States), Hamamatsu Photonics (Japan), Quest Medical Imaging (Netherland), Shimadzu (Japan) and Fluoptics (France) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Fluorescence-Guided Surgery System market by Type (PDE system, VS3 iridium system, SPY system and Others), Application (Sentinel Lymph Node (SLN) Mapping, Identification of Solid Tumors, Lymphography, Angiography and Anatomical Imaging) and Region.



On the basis of geography, the market of Fluorescence-Guided Surgery System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Doctor will boost the Fluorescence-Guided Surgery System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2021 Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities. Fluorescence imaging refers to imaging techniques that use fluorescent dyes to direct light to specific anatomical structures. Tissues or lesions that are nearly invisible under normal white light become visible by using targeted dyes in conjunction with specific light wavelengths. The VISERA ELITE II laparoscopic imaging system from Olympus already includes fluorescence imaging technology. VISERA ELITE II employs near-infrared light to identify blood vessels or lymph nodes beneath the surface tissues, allowing surgeons to perform safer procedures with lower complication risks. The Quest technology acquired is intended to expand Olympus's opportunities in this field.



Market Drivers
  • Swelling Number of Global Surgical Procedures
  • Accumulative Occurrence of Target Diseases
  • No Need for Special Equipment

Opportunities
  • Expanding the Approval of Fluorescence-Guided Surgery System for Cancer Treatment
  • Low Cost of Fluorescence-Guided Surgery System

Restraints
  • Protracted Authorization Events

Challenges
  • Increase Surgical Time
  • Need Patient Transportation


Key Target Audience
Fluorescence-Guided Surgery System Provider, Hospital, Clinic, Government, Corporate and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • PDE system
  • VS3 iridium system
  • SPY system
  • Others
By Application
  • Sentinel Lymph Node (SLN) Mapping
  • Identification of Solid Tumors
  • Lymphography
  • Angiography
  • Anatomical Imaging
By End Users
  • Doctor
  • Physician
  • Patients
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Swelling Number of Global Surgical Procedures
      • 3.2.2. Accumulative Occurrence of Target Diseases
      • 3.2.3. No Need for Special Equipment
    • 3.3. Market Challenges
      • 3.3.1. Increase Surgical Time
      • 3.3.2. Need Patient Transportation
    • 3.4. Market Trends
      • 3.4.1. Cumulative Acceptance of Fluorescence-Guided Surgery for Treatment of Different Type of Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fluorescence-Guided Surgery System, by Type, Application, End Users and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Fluorescence-Guided Surgery System (Value)
      • 5.2.1. Global Fluorescence-Guided Surgery System by: Type (Value)
        • 5.2.1.1. PDE system
        • 5.2.1.2. VS3 iridium system
        • 5.2.1.3. SPY system
        • 5.2.1.4. Others
      • 5.2.2. Global Fluorescence-Guided Surgery System by: Application (Value)
        • 5.2.2.1. Sentinel Lymph Node (SLN) Mapping
        • 5.2.2.2. Identification of Solid Tumors
        • 5.2.2.3. Lymphography
        • 5.2.2.4. Angiography
        • 5.2.2.5. Anatomical Imaging
      • 5.2.3. Global Fluorescence-Guided Surgery System by: End Users (Value)
        • 5.2.3.1. Doctor
        • 5.2.3.2. Physician
        • 5.2.3.3. Patients
        • 5.2.3.4. Others
      • 5.2.4. Global Fluorescence-Guided Surgery System Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Fluorescence-Guided Surgery System (Price)
      • 5.3.1. Global Fluorescence-Guided Surgery System by: Type (Price)
  • 6. Fluorescence-Guided Surgery System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Olympus (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Karl Storz (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novadaq Technologies, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PerkinElmer (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Stryker (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hamamatsu Photonics (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Quest Medical Imaging (Netherland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Shimadzu (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Fluoptics (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Fluorescence-Guided Surgery System Sale, by Type, Application, End Users and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Fluorescence-Guided Surgery System (Value)
      • 7.2.1. Global Fluorescence-Guided Surgery System by: Type (Value)
        • 7.2.1.1. PDE system
        • 7.2.1.2. VS3 iridium system
        • 7.2.1.3. SPY system
        • 7.2.1.4. Others
      • 7.2.2. Global Fluorescence-Guided Surgery System by: Application (Value)
        • 7.2.2.1. Sentinel Lymph Node (SLN) Mapping
        • 7.2.2.2. Identification of Solid Tumors
        • 7.2.2.3. Lymphography
        • 7.2.2.4. Angiography
        • 7.2.2.5. Anatomical Imaging
      • 7.2.3. Global Fluorescence-Guided Surgery System by: End Users (Value)
        • 7.2.3.1. Doctor
        • 7.2.3.2. Physician
        • 7.2.3.3. Patients
        • 7.2.3.4. Others
      • 7.2.4. Global Fluorescence-Guided Surgery System Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Fluorescence-Guided Surgery System (Price)
      • 7.3.1. Global Fluorescence-Guided Surgery System by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fluorescence-Guided Surgery System: by Type(USD Million)
  • Table 2. Fluorescence-Guided Surgery System PDE system , by Region USD Million (2016-2021)
  • Table 3. Fluorescence-Guided Surgery System VS3 iridium system , by Region USD Million (2016-2021)
  • Table 4. Fluorescence-Guided Surgery System SPY system , by Region USD Million (2016-2021)
  • Table 5. Fluorescence-Guided Surgery System Others , by Region USD Million (2016-2021)
  • Table 6. Fluorescence-Guided Surgery System: by Application(USD Million)
  • Table 7. Fluorescence-Guided Surgery System Sentinel Lymph Node (SLN) Mapping , by Region USD Million (2016-2021)
  • Table 8. Fluorescence-Guided Surgery System Identification of Solid Tumors , by Region USD Million (2016-2021)
  • Table 9. Fluorescence-Guided Surgery System Lymphography , by Region USD Million (2016-2021)
  • Table 10. Fluorescence-Guided Surgery System Angiography , by Region USD Million (2016-2021)
  • Table 11. Fluorescence-Guided Surgery System Anatomical Imaging , by Region USD Million (2016-2021)
  • Table 12. Fluorescence-Guided Surgery System: by End Users(USD Million)
  • Table 13. Fluorescence-Guided Surgery System Doctor , by Region USD Million (2016-2021)
  • Table 14. Fluorescence-Guided Surgery System Physician , by Region USD Million (2016-2021)
  • Table 15. Fluorescence-Guided Surgery System Patients , by Region USD Million (2016-2021)
  • Table 16. Fluorescence-Guided Surgery System Others , by Region USD Million (2016-2021)
  • Table 17. South America Fluorescence-Guided Surgery System, by Country USD Million (2016-2021)
  • Table 18. South America Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 19. South America Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 20. South America Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 21. Brazil Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 22. Brazil Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 23. Brazil Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 24. Argentina Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 25. Argentina Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 26. Argentina Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 27. Rest of South America Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 28. Rest of South America Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 29. Rest of South America Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 30. Asia Pacific Fluorescence-Guided Surgery System, by Country USD Million (2016-2021)
  • Table 31. Asia Pacific Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 32. Asia Pacific Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 33. Asia Pacific Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 34. China Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 35. China Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 36. China Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 37. Japan Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 38. Japan Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 39. Japan Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 40. India Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 41. India Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 42. India Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 43. South Korea Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 44. South Korea Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 45. South Korea Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 46. Taiwan Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 47. Taiwan Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 48. Taiwan Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 49. Australia Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 50. Australia Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 51. Australia Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 55. Europe Fluorescence-Guided Surgery System, by Country USD Million (2016-2021)
  • Table 56. Europe Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 57. Europe Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 58. Europe Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 59. Germany Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 60. Germany Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 61. Germany Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 62. France Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 63. France Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 64. France Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 65. Italy Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 66. Italy Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 67. Italy Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 68. United Kingdom Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 69. United Kingdom Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 70. United Kingdom Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 71. Netherlands Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 72. Netherlands Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 73. Netherlands Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 74. Rest of Europe Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 75. Rest of Europe Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 76. Rest of Europe Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 77. MEA Fluorescence-Guided Surgery System, by Country USD Million (2016-2021)
  • Table 78. MEA Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 79. MEA Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 80. MEA Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 81. Middle East Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 82. Middle East Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 83. Middle East Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 84. Africa Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 85. Africa Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 86. Africa Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 87. North America Fluorescence-Guided Surgery System, by Country USD Million (2016-2021)
  • Table 88. North America Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 89. North America Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 90. North America Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 91. United States Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 92. United States Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 93. United States Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 94. Canada Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 95. Canada Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 96. Canada Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 97. Mexico Fluorescence-Guided Surgery System, by Type USD Million (2016-2021)
  • Table 98. Mexico Fluorescence-Guided Surgery System, by Application USD Million (2016-2021)
  • Table 99. Mexico Fluorescence-Guided Surgery System, by End Users USD Million (2016-2021)
  • Table 100. Fluorescence-Guided Surgery System: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Fluorescence-Guided Surgery System: by Type(USD Million)
  • Table 112. Fluorescence-Guided Surgery System PDE system , by Region USD Million (2022-2027)
  • Table 113. Fluorescence-Guided Surgery System VS3 iridium system , by Region USD Million (2022-2027)
  • Table 114. Fluorescence-Guided Surgery System SPY system , by Region USD Million (2022-2027)
  • Table 115. Fluorescence-Guided Surgery System Others , by Region USD Million (2022-2027)
  • Table 116. Fluorescence-Guided Surgery System: by Application(USD Million)
  • Table 117. Fluorescence-Guided Surgery System Sentinel Lymph Node (SLN) Mapping , by Region USD Million (2022-2027)
  • Table 118. Fluorescence-Guided Surgery System Identification of Solid Tumors , by Region USD Million (2022-2027)
  • Table 119. Fluorescence-Guided Surgery System Lymphography , by Region USD Million (2022-2027)
  • Table 120. Fluorescence-Guided Surgery System Angiography , by Region USD Million (2022-2027)
  • Table 121. Fluorescence-Guided Surgery System Anatomical Imaging , by Region USD Million (2022-2027)
  • Table 122. Fluorescence-Guided Surgery System: by End Users(USD Million)
  • Table 123. Fluorescence-Guided Surgery System Doctor , by Region USD Million (2022-2027)
  • Table 124. Fluorescence-Guided Surgery System Physician , by Region USD Million (2022-2027)
  • Table 125. Fluorescence-Guided Surgery System Patients , by Region USD Million (2022-2027)
  • Table 126. Fluorescence-Guided Surgery System Others , by Region USD Million (2022-2027)
  • Table 127. South America Fluorescence-Guided Surgery System, by Country USD Million (2022-2027)
  • Table 128. South America Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 129. South America Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 130. South America Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 131. Brazil Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 132. Brazil Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 133. Brazil Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 134. Argentina Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 135. Argentina Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 136. Argentina Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 137. Rest of South America Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 138. Rest of South America Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 139. Rest of South America Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 140. Asia Pacific Fluorescence-Guided Surgery System, by Country USD Million (2022-2027)
  • Table 141. Asia Pacific Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 142. Asia Pacific Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 143. Asia Pacific Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 144. China Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 145. China Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 146. China Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 147. Japan Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 148. Japan Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 149. Japan Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 150. India Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 151. India Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 152. India Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 153. South Korea Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 154. South Korea Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 155. South Korea Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 156. Taiwan Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 157. Taiwan Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 158. Taiwan Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 159. Australia Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 160. Australia Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 161. Australia Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 162. Rest of Asia-Pacific Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 164. Rest of Asia-Pacific Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 165. Europe Fluorescence-Guided Surgery System, by Country USD Million (2022-2027)
  • Table 166. Europe Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 167. Europe Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 168. Europe Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 169. Germany Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 170. Germany Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 171. Germany Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 172. France Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 173. France Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 174. France Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 175. Italy Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 176. Italy Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 177. Italy Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 178. United Kingdom Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 179. United Kingdom Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 180. United Kingdom Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 181. Netherlands Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 182. Netherlands Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 183. Netherlands Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 184. Rest of Europe Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 185. Rest of Europe Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 186. Rest of Europe Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 187. MEA Fluorescence-Guided Surgery System, by Country USD Million (2022-2027)
  • Table 188. MEA Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 189. MEA Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 190. MEA Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 191. Middle East Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 192. Middle East Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 193. Middle East Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 194. Africa Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 195. Africa Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 196. Africa Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 197. North America Fluorescence-Guided Surgery System, by Country USD Million (2022-2027)
  • Table 198. North America Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 199. North America Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 200. North America Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 201. United States Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 202. United States Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 203. United States Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 204. Canada Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 205. Canada Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 206. Canada Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 207. Mexico Fluorescence-Guided Surgery System, by Type USD Million (2022-2027)
  • Table 208. Mexico Fluorescence-Guided Surgery System, by Application USD Million (2022-2027)
  • Table 209. Mexico Fluorescence-Guided Surgery System, by End Users USD Million (2022-2027)
  • Table 210. Fluorescence-Guided Surgery System: by Type(USD/Units)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fluorescence-Guided Surgery System: by Type USD Million (2016-2021)
  • Figure 5. Global Fluorescence-Guided Surgery System: by Application USD Million (2016-2021)
  • Figure 6. Global Fluorescence-Guided Surgery System: by End Users USD Million (2016-2021)
  • Figure 7. South America Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 8. Asia Pacific Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 9. Europe Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 10. MEA Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 11. North America Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 12. Global Fluorescence-Guided Surgery System: by Type USD/Units (2016-2021)
  • Figure 13. Global Fluorescence-Guided Surgery System share by Players 2021 (%)
  • Figure 14. Global Fluorescence-Guided Surgery System share by Players (Top 3) 2021(%)
  • Figure 15. Global Fluorescence-Guided Surgery System share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Olympus (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Olympus (Japan) Revenue: by Geography 2021
  • Figure 19. Karl Storz (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Karl Storz (Germany) Revenue: by Geography 2021
  • Figure 21. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 23. Novadaq Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Novadaq Technologies, Inc. (United States) Revenue: by Geography 2021
  • Figure 25. PerkinElmer (United States) Revenue, Net Income and Gross profit
  • Figure 26. PerkinElmer (United States) Revenue: by Geography 2021
  • Figure 27. Stryker (United States) Revenue, Net Income and Gross profit
  • Figure 28. Stryker (United States) Revenue: by Geography 2021
  • Figure 29. Hamamatsu Photonics (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Hamamatsu Photonics (Japan) Revenue: by Geography 2021
  • Figure 31. Quest Medical Imaging (Netherland) Revenue, Net Income and Gross profit
  • Figure 32. Quest Medical Imaging (Netherland) Revenue: by Geography 2021
  • Figure 33. Shimadzu (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Shimadzu (Japan) Revenue: by Geography 2021
  • Figure 35. Fluoptics (France) Revenue, Net Income and Gross profit
  • Figure 36. Fluoptics (France) Revenue: by Geography 2021
  • Figure 37. Global Fluorescence-Guided Surgery System: by Type USD Million (2022-2027)
  • Figure 38. Global Fluorescence-Guided Surgery System: by Application USD Million (2022-2027)
  • Figure 39. Global Fluorescence-Guided Surgery System: by End Users USD Million (2022-2027)
  • Figure 40. South America Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 41. Asia Pacific Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 42. Europe Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 43. MEA Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 44. North America Fluorescence-Guided Surgery System Share (%), by Country
  • Figure 45. Global Fluorescence-Guided Surgery System: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Olympus (Japan)
  • Karl Storz (Germany)
  • Medtronic (Ireland)
  • Novadaq Technologies, Inc. (United States)
  • PerkinElmer (United States)
  • Stryker (United States)
  • Hamamatsu Photonics (Japan)
  • Quest Medical Imaging (Netherland)
  • Shimadzu (Japan)
  • Fluoptics (France)
Select User Access Type

Key Highlights of Report


Jul 2022 221 Pages 52 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fluorescence-Guided Surgery System Market Quantitative research analysis
Global Fluorescence-Guided Surgery System Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Olympus (Japan), Karl Storz (Germany), Medtronic (Ireland), Novadaq Technologies, Inc. (United States), PerkinElmer (United States), Stryker (United States), Hamamatsu Photonics (Japan), Quest Medical Imaging (Netherland), Shimadzu (Japan) and Fluoptics (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Cumulative Acceptance of Fluorescence-Guided Surgery for Treatment of Different Type of Cancer" is seen as one of major influencing trends for Fluorescence-Guided Surgery System Market during projected period 2021-2027.
The Fluorescence-Guided Surgery System market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Fluorescence-Guided Surgery System Market Report?

Have a Query? Click Here

Other Related Reports

Organ Transport Service Comprehensive Study by Type (Air Transport, Road Transport), Application (Hospitals, Clinical Laboratories), Service (Long Distance Transport, Bariatric Transport, Ambulance S...
$ 3800
RNA Probe Comprehensive Study by Type (Plus-Sense RNA Probes, Minus-Sense RNA Probes, Antisense RNA Probes), Application (In Northern blotting, RNase protection assays, In situ hybridization, Souther...
$ 3800
Vehicle Mobile CT Comprehensive Study by Application (Hospital, Clinic), Vehicle Type (Car, Truck, Others) Players and Region - Global Market Outlook to 2027
$ 3800
Pets Vitamins and Supplement Comprehensive Study by Type (Tablets, Powder, Chewable, Other), Application (Multivitamins, Prebiotics & Probiotics, Calming, Other), End Users (Commercial, Residential, ...
$ 4000
Pharmacy Safes Comprehensive Study by Type (Fire Rated, High Securities Safes, Burglary Safes, Others), Application (Hospital, Clinic, Others) Players and Region - Global Market Outlook to 2027
$ 3800
Healthcare Finance Solution Comprehensive Study by Type (Equipment And Technology Finance, Working Capital Finance, Project Finance Solutions, Corporate Lending), Application (Hospitals, Laboratories...
$ 3600